Increased serum neopterin levels in adults with Down syndrome

We quantitated serum neopterin levels in Down syndrome (DS), normal controls, Alzheimer's disease, multiple sclerosis and other neurological diseases. We then analyzed the relationships with age, sex, apolipoprotein E (Apo E) phenotype, and amyloid beta protein 1–40 (Aβ40) and 1–42 (Aβ42) level...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neuroimmunology 2005-07, Vol.164 (1), p.129-133
Main Authors: Mehta, Pankaj D., Patrick, Bruce A., Dalton, Arthur J., Patel, Bindu, Mehta, Sangita P., Pirttila, Tuula, Coyle, Patricia K.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We quantitated serum neopterin levels in Down syndrome (DS), normal controls, Alzheimer's disease, multiple sclerosis and other neurological diseases. We then analyzed the relationships with age, sex, apolipoprotein E (Apo E) phenotype, and amyloid beta protein 1–40 (Aβ40) and 1–42 (Aβ42) levels. Neopterin levels were higher in DS than all other groups. Levels in young DS (41 years) were similar. There was no significant correlation between neopterin levels and age, sex, Apo E phenotype, and Aβ40 or Aβ42 levels in DS. This lack of correlation between neopterin and Aβ levels suggests that the higher neopterin concentrations in DS group reflect inflammatory cell activation rather than AD neuropathology.
ISSN:0165-5728
1872-8421
DOI:10.1016/j.jneuroim.2005.03.010